Intesticult Organoid Growth Medium(Human) (Ambis 2218293) Tender, USA - 100903596

Procurement Summary

Country : USA

Summary : Intesticult Organoid Growth Medium(Human) (Ambis 2218293)

Deadline : 16 May 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 100903596

Document Ref. No. : SS-NIAID-24-2218293

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : BETHESDA, MD 20892
Primary Point of Contact : Kimberly Rubio
kimberly.rubio@nih.gov
Phone Number 3017616892

Secondary Point of Contact : Tonia Alexander
talexander@niaid.nih.gov
Phone Number 2406695124
USA
Email :kimberly.rubio@nih.gov

Tender Details

Description

This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America-s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)-s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.



The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:



WE ARE SEEKING INTESTICULT ORGANOID GROWTH MEDIUM (HUMAN), A CELL CULTURE MEDIUM FOR ESTABLISHMENT AND MAINTENANCE OF HUMAN INTESTENIAL ORGANOIDS.



The essential specifications and capabilities needed are:



1. IntestiCult OGM Human Basal Medium, 50 mL

2. Organoid Supplement, 50 mL



Capability Statement/Information Sought

All capable vendors should respond with a brief capability statement demonstrating an equal product that is manufactured in the United States by May 16, 2024, by 11:00 AM EST.



Capabilities statement must also include the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UE ID# with an active SAM.gov registration, and a tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of capability.



Submission Instructions

Interested businesses who consider themselves qualified to provide an equal product that is manuf...
Active Contract Opportunity Notice ID SS-NIAID-24-2218293 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: May 06, 2024 07:43 am EDT
Original Response Date: May 16, 2024 11:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: May 31, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6509 - DRUGS AND BIOLOGICALS, VETERINARY USE
NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice